EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension

Yijia Wang, Xin Li, Zhihua Huang, Anqi Duan, Qi Wang, Luyang Gao, Sicong Li, Qing Zhao, Tao Yang iD, Zhihui Zhao, Qin Luo, Zhihong Liu iD

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 05.11.2026. Verfasst von Yijia Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Respiratory and Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Stroke Volume, Heart Failure, Pulmonary Embolism. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic thromboembolic pulmonary hypertension (CTEPH) and left heart disease, particularly heart failure with preserved ejection fraction (HFpEF), show overlapping clinical features despite distinct pathophysiology.

Objectives

The HFpEF‐ABA algorithm (age, body mass index, atrial fibrillation) was used to characterize HFpEF pretest probability in patients with CTEPH and evaluate its association with left heart disease and clinical worsening.

Methods

Among 466 patients with CTEPH stratified by HFpEF‐ABA score (low < 25%, intermediate 25%–74%, high ≥ 75%), Spearman's correlation assessed associations with common left heart disease comorbidities. Kaplan‐Meier analysis and Cox regression evaluated associations with clinical worsening, with restricted cubic splines assessing the dose‐response relationship and non‐linearity. Subgroup analyses by sex, smoking, alcohol use, hypertension, coronary artery disease, and obstructive sleep apnea assessed the consistency. We also evaluated whether adding the HFpEF‐ABA score improved COMPERA 2.0 discrimination for clinical worsening.

Results

Intermediate and high HFpEF probability was found in 52.4% ( n = 244) and 9.0% ( n = 42), respectively. After adjustment, each standard deviation increase in HFpEF probability was associated with an approximately 73% increase in clinical worsening ( p < 0.001). Results were consistent for HFpEF probability ( p < 0.05), with no significant subgroup interactions. Adding HFpEF‐ABA with COMPERA 2.0 improved discrimination, increasing the C‐index increasing from 0.532 to 0.634 ( p = 0.012).

Conclusions

Assessing HFpEF probability in patients with CTEPH identifies those at high risk for this comorbidity and improves the precision when integrated with existing risk models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryStroke VolumeHeart FailurePulmonary EmbolismVentricular Function, LeftHumansFemaleMalePrognosisChronic DiseaseRisk FactorsAgedRetrospective StudiesMiddle AgedRisk AssessmentFollow-Up Studies

Stichwörter der Autor:innen

HFpEF‐ABA scorechronic thromboembolic pulmonary hypertensionclinical worseningheart failure with preserved ejection fraction

Autor:innen und Institutionen

  • Center for Respiratory and Pulmonary Vascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Tao Yang, Zhihong Liu

Förderung

  • National High Level Hospital Clinical Research Funding
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Key Research and Development Program of China
  • Beijing Natural Science Foundation
  • CAMS Innovation Fund for Medical Sciences (CIFMS)
  • The Artificial Intelligence and Information Technology Application Fund of Fuwai Hospital, Chinese Academy of Medical Sciences
  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program (Grade C) of China Postdoctoral Science Foundation

Zitieren

APA

Wang, Y., Li, X., Huang, Z., Duan, A., Wang, Q., Gao, L., Li, S., Zhao, Q., Yang, T., Zhao, Z., Luo, Q., & Liu, Z. (2026). Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70503

Vancouver

Wang Y, Li X, Huang Z, Duan A, Wang Q, Gao L, et al. Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70503

BibTeX
@article{Wang2026,
  author = {Wang, Yijia and Li, Xin and Huang, Zhihua and Duan, Anqi and Wang, Qi and Gao, Luyang and Li, Sicong and Zhao, Qing and Yang, Tao and Zhao, Zhihui and Luo, Qin and Liu, Zhihong},
  title = {Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/clc.70503}
}
Kostenlos starten →